What's Hot
View all perspectives
Dr. Rachel Tate uptoTate
3 years 6 months ago
Poster #POS0633 detailed HUR-BIO PsA pts started bDMARDs w/in 18 months of dx vs, on ave, 3x longer to start bDMARDs in RA pts in real life data. What do you drugs do you start in your PsA pts after dx? Feel free to detail me below! #EULAR2021 @RheumNow
Robert B Chao, MD doctorRBC
3 years 6 months ago
“Let thy food by thy medicine and thy medicine be thy food”
Western diet - greatest enemy of chronic inflammatory conditions?
⬆️salt
⬆️refined carbs
⬆️omega 6 fatty acids
⬇️fiber, long chain omega 3 FA
Abs#OP6882
#EULAR2021 @RheumNow
Richard Conway RichardPAConway
3 years 6 months ago
Dr Schapp on nasal Staph Aureus eradication in ANCA vasculitis. Neither the presence or eradication of Staph Aureus appeared to influence the vasculitis @RheumNow #EULAR2021 Abstr#POS0249 https://t.co/bxtaznejNk
Eric Dein ejdein1
3 years 6 months ago
Practical tip from #EULAR2021 Pres6882: The difference a double bond makes:
⭐️Omega-3: Anti-inflammatory!
⭐️Omega-6: Pro-Inflammatory
The ratio of ⬆️ omega-3 : ⬇️ omega-6 is key to anti-inflammatory diet
@Rheumnow https://t.co/RtGWsDIouC
k dao KDAO2011
3 years 6 months ago
A giant in our field. He has been my teacher for most of my career (since fellowship). He taught me how to care for patients, conduct research, & teach. My favorite quote is "If you're doing nothing, you're not doing anybody any good!" What is something he taught you? @rheumnow https://t.co/Fyw1u8wln8
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 6 months ago
Would you use #Telemedicine (TM) to follow-up #SLE patients post #COVID? Dr So showed in an RCT (N=122),patient satisfaction and time-to-review were better in TM vs Face-to-Face. Although none had COVID, >pts in TM were hospitalised and trend to⬆️FU #EULAR2021 #POS1164 @RheumNow https://t.co/p7aWv4AVm7
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 6 months ago
@almirall_m I don't monitor routinely. High rate of seroconversion post-TNFi but only small cases of TNFi-induced SLE (mild mostly). To screen with ANA if develop SLE features
Robert B Chao, MD doctorRBC
3 years 6 months ago
Apremilast in Behcet’s - RELIEF European subgroup analysis
⬇️oral ulcer count, ulcer pain, disease activity
⬆️QoL
⭐️results consistent with general population
Abs#POS0254
#EULAR2021 @RheumNow https://t.co/NVGt4TjkYY
Richard Conway RichardPAConway
3 years 6 months ago
Dr Marsman presents positive RCT of Rituximab in PMR. GC-free remission 48% vs 21% (p=0.049) GC<=5mg 100% vs 47% (p=0.005) @RheumNow #EULAR2021 Abstr#POS0343 https://t.co/tjkKTS6DMN
Robert B Chao, MD doctorRBC
3 years 6 months ago
Gut dysbiosis linked to worse disease status in AxSpA
⭐️higher dysbiosis associated w/ worse EvalGlobal, ASDAS-CRP, BASDAI, BASFI, VAS pain
⭐️comparing dysbiosis vs. non-dysbiosis group - significant difference in BASDAI, BASFI, EvalGlobal
Abs#POS0237
#EULAR2021 @RheumNow
David Liew drdavidliew
3 years 6 months ago
Looking at those results (distributed evenly each side of 'maybe a little') it seems we're collectively uncertain right now about what JAK1 selectivity really means in practice.
Hopefully we get stronger clinical insights (toxicity/efficacy) in coming years!
#EULAR2021 @RheumNow https://t.co/jFhVGqpOnb
Robert B Chao, MD doctorRBC
3 years 6 months ago
LNA043 - modified, recombinant human angiopoietin-like 3 (ANGPTL3) protein
⭐️proof of concept trial on patients with articular cartilage lesions
⭐️regeneration of damaged cartilage
⭐️treatment effect in cartilage volume
⭐️phase IIb pending
Abs#POS0277
#EULAR2021 @RheumNow
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 6 months ago
Which biomarkers could guide csDMARDs tapering in #RA patients in #remission? Dr Gul reported in a cohort study using a tapering protocol, 35% had relapsed. Risk score for sustained remission comprise IRC<2%, MSK-US PD=0 and RAQoL=<1 (AUC=0.89) #EULAR2021 #OP0182 @RheumNow https://t.co/y1Y6ug7f3w
Jeffrey Sparks MD MMSc jeffsparks
3 years 6 months ago
How does MTX affect kidney function/adverse events? Pre-specified analysis of DBRCT: MTX 15-20mg/wk (n=2391) vs. PBO (n=2395) both with folic acid over median f/u 23 months
✅We demonstrated kidney safety of MTX
⚡️⚡️Also a *suggestion* of LESS decline in eGFR for MTX than PBO https://t.co/SZXloLRmnj
Md Yuzaiful Md Yusof Yuz6Yusof
3 years 6 months ago
Due to significant interest in our Tweet about #POS0204 #EULAR2021, let's vote. Would you monitor #ANA in patients receiving therapy with #TNF inhibitors?🧐@RheumNow
Poster Hall